The interplay of persistent PI3K-AKT-mTORC activation and β1 expression were evaluated to gain insight into the underlying mechanism of PI3K-AKT-mTOR pathway activation in IR MCL cells. The gene discussed is MTOR; the disease is mantle cell lymphoma.